Please use a minimum of three unique search words
Our search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Olumiant ® (baricitinib)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Does Olumiant® (baricitinib) contain gluten or lactose?
Baricitinib does not contain gluten or lactose.
What ingredients do baricitinib tablets contain?
The tablets contain mannitol that is developed from maize or wheat starch. They do not contain ingredients that come from barley, oat, rye or spelt.1
The active ingredient of Olumiant is baricitinib.2
The tablet cores contain2
- cellulose, microcrystalline
- croscarmellose sodium
- magnesium stearate
The film coating contains2
- iron oxide red (E172)
- lecithin (soya) (E322)
- poly (vinyl alcohol)
- titanium dioxide (E171)
This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e., essentially “sodium- free”.2
Olumiant is contraindicated in case of hypersensitivity to the active substance or to any of the excipients.2
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2Olumiant [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 24 February 2022